Display options
Share it on

Ther Umsch. 2013 Apr;70(4):231-5; discussion 236. doi: 10.1024/0040-5930/a000394.

[Colorectal cancer screening].

Therapeutische Umschau. Revue therapeutique

[Article in German]
Hermann Brenner, Christian Stock, Michael Hoffmeister

Affiliations

  1. Abteilung Klinische Epidemiologie und Alternsforschung, Deutsches Krebsforschungszentrum, Heidelberg. [email protected]

PMID: 23535550 DOI: 10.1024/0040-5930/a000394

Abstract

One of the most common cancers, colorectal cancer is a leading cause of cancer deaths worldwide. The vast majority of colorectal carcinomas develop slowly from easily-removed precursors (adenomas), and in contrast to most other types of cancer, chances of prevention and early detection are very good. Tests for fecal occult blood, sigmoidoscopy and colonoscopy are frequently recommended and widely used. Most western countries have initiated population-wide screening programs for colorectal cancer, with the goal of greatly reducing incidence and mortality. Various models for screening programs and different screening examinations have been proposed and implemented. Evidence from a range of countries shows that the highest participation rates are obtained when programs are designed to invite eligible individuals to come in for screening.

MeSH terms

Publication Types